Radiofrequency ablation of the heart is a curative treatment that generally does not affect life expectancy and allows for long-term survival. The exact life expectancy still depends on the patient’s own health status.
Radiofrequency ablation is currently an important treatment for tachyarrhythmias. It is the first-line treatment for atrioventricular nodal tachycardia, atrioventricular tachycardia and paroxysmal atrial fibrillation.
The procedure is to determine the target point of ablation based on intracardiac electrophysiologic examination to clarify the arrhythmia, and then place the catheter through the femoral vein or the femoral artery to reach the target point according to the location of the target point. Depending on the type of arrhythmia, the ablation site is discharged. Successful ablation is detected (criteria include the inability to re-trigger the existing arrhythmia, loss of bypass reversal function, etc.).
It is recommended that active postoperative review and treatment as prescribed by the doctor can help improve prognosis and prolong survival.